Maybe their trying to keep it on the down low. ; )
LOL
wook
With the pending RS, partnership, CA, CSM, curing cancer and now no TICKETS..........!
it's no wonder we have only traded 200K today...............!
PPHM Stock Message Board http://investorshangout.com/Peregrine-Pharmac...PHM-55152/
No, I am guessing they do communicate with the Investigator and are on friendly terms. However, they publicly state they have no control and in terms of a lawsuit, I would think this would go a long way in protecting them. Good luck trying to prove differently.
The fact that they issue a PR and include a quote is nothing more than relaying based on what the quote says this is what we think is happening (legally speaking).
IMO someone would have a tough time holding them accountable for the quote. If a company says we plan to make a lot of money selling widgets this year so loan us money based on the following. They show quotes from 10 companies that buy widgets from them saying they plan on buying a lot of widgets due to projected business the rest of the year and the business doesn't materialize, I don't think the lender has a case unless he can show their was definite intent to mislead. Tough to prove. Of course I don't know it all. Just a little bit.
I am sure there is a conspiracy there somewhere. Anybody can sue anybody. There is always a fool who is willing to make the attorneys money.
NiceFind CP, and Many Companies on Enterey's List...
have done business with PPHM or have been involved in recent speculation too.
Seems Enterey could offer a good service for potential partnerships.
Thanks again for all your substantial contributions to this board!
GLTA Real Stockholders, Employees, Patients, and Their Families too!
Bayer in Berkeley...ticket to what?
Peregrine is IT Management software utilized to manage/document incidents, changes, problems, assets.
Peregrine Pharmaceuticals added in Enterey's reference list.
Reference list
Quote:
We have significant experience working with leading Pharmaceutical, Biotechnology, and Medical Device manufacturers as well as growing start-up life sciences companies. Selected examples include AbbVie, Bayer Healthcare, Biogen Idec (Idec Pharmaceuticals), Illumina, Isis Pharmaceuticals, Novartis, Peregrine Pharmaceuticals, and Valeant Pharmaceuticals.
VeryCurious, All 3 JobLinks Have DeadEnd Info Links...
Meaning, if you follow your 3 links and then click each one for more info, they all show up as Job Not Found.... strange huh!?!?
GLTA!
I'm really rooting for JAKE and you, too.
These crazy connect the dots stuff..
That position is for an IT Assistant Analyst; therefore, they would be resolving Tickets which are generated by the Employees. It looks like Bayer is using the Peregrine Ticketing Management System.
First, you really think Peregrine has no control over when an IST sponsored by PPHM releases data? C'mon...you're smarter than that. Even humoring you on that point, the PR and the select quote in the PR was issued by PPHM, something that wasn't needed, but that was done.
So, once the quote was issued in the PPHM PR, it became a company issue not just an IST issue.
Lets take it to the extreme, Company A issues a statement that "Our lead investigator in our second-most important trial representing a multi-billion dollar opportunity, has patients living as long as 18 months and will publish the full data set later this year.
Then company A raises $20 million and the stock tanks 50%. If they don't issue that full data set, I'd say anyone who sold at a loss after March 14 will be on the doorstep of the Faruqi and Faruqi firm on Jan. 1 and has a great case IMO.
Just a guess:
http://en.wikipedia.org/wiki/Peregrine_Systems
Perhaps Bayer is using HP's Peregrine IT management system
Bayer hires manager for Peregrine Tickets!
see August 23 2014 - Manage Peregrine Tickets (help desk) to ensure timely and appropriate resolution;
Anybody knows what that is : Peregrine Tickets?
Jobs listed since Saterday morning. Appeared suddenly in my Peregrine Pharmaceuticals list but with Bayer as the employer!
Anther source
And a 3rd
the liver trial is an IST and they have said many times that they do not control the release of information on the trial. The paragraph that was included was a quote from Dr.Yopp saying he intended to present the data by the end of the year. I do not think pphm is responsible for the statements of Dr. Yopp and whether or not he delivers on them.
A little birdie told me that it will be on the 16th.
Andy C.
I'm hoping you make a mint off of it (and the rest of us also).
Yes. It has in the past pre-empted a late day surge.
Yes, PPHM Removing Partnering Tab on Website is...
a Much better topic for discussion.
I thought I was being careful while posting what appears to include Bayer amongst the many possible suitors that could be interested in partnering with PPHM in any of PPHM's Piepline. Many doubt PPHM has any other companies interested in partnering, so that was the purpose of my original post.
As I pointed out, my link only showed "research" of partners by Bayer, which is certainly not a confirmation... only their consideration of potential partners list of which PPHM is only 1 of 25 companies listed.
I'm not trying to start rumours, but rather trying to stop rumours by the many that say PPHM is not in any current partnering negotiations.
My post only implies Bayer was interested as recently as 2nd quarter 2014 and in no way does it actually say anything has been decided by either party.
Thanks for your post regarding Sorafenib+Bavi. The next couple weeks may be exciting!
GLTA!
I'd argue the safe harbor would be sufficient if they weren't continuously financing the company without providing updated guidance that the "full data set" is no longer expected this year if that's the case.
You see, based on their own website, the liver trial is the 2nd most important clinical trial they have and the PR from March 14, 2014 is available. So, if investors purchased common or preferred shares between March-today under the premise of their PR on March 14, that "the full data set would be released later this year" and the company continues to sell PPHMP and/or ATM shares without updating that type of guidance to reflect a change, they're walking a very fine line IMO. And when you start selling shares, it gets sketchy.
At the very least, it opens the door for some pissed off shareholders to start another lawsuit.